BMSSC
HCAT icon

B. Metzler seel. Sohn & Co’s Health Catalyst HCAT Stock Holding History

B. Metzler seel. Sohn & Co’s Portfolio HCAT Stock Details HCAT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-85,740
Closed -$868K – 758
2023
Q3 		$868K Sell
85,740
-75,642
-47% -$903K 0.01% 493
2023
Q2 		$2.02M Buy
161,382
+86,348
+115% +$1.03M 0.03% 376
2023
Q1 		$876K Buy
75,034
+5,928
+9% +$75.6K 0.01% 462
2022
Q4 		$735K Hold
69,106
– – 0.01% 487
2022
Q3 		$670K Buy
69,106
+2,858
+4% +$37.8K 0.01% 492
2022
Q2 		$960K Buy
66,248
+13,385
+25% +$228K 0.02% 443
2022
Q1 		$1.38M Buy
+52,863
New +$1.5M 0.02% 417

Other funds holding HCAT

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
DG
Daventry Group New York $133M AUM 32.28% 1-Year Est. Return
Impax Asset Management Group
Impax Asset Management Group London, United Kingdom $15.4B AUM 26.43% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

B. Metzler seel. Sohn & Co's HCAT Position: Q4 2023 in Review

B. Metzler seel. Sohn & Co sold out of Health Catalyst (HCAT) in Q4 2023, closing a stake of 85,740 shares — an estimated $868K sold.

B. Metzler seel. Sohn & Co first reported a position in HCAT in Q1 2022 and held it in 7 quarters. The position peaked at $2.02M in Q2 2023. 167 funds tracked by Wall St. Rank hold HCAT as of Q4 2023.

  • B. Metzler seel. Sohn & Co reported no remaining Health Catalyst position as of Q4 2023 after selling out during the quarter.
  • B. Metzler seel. Sohn & Co sold 85,740 Health Catalyst shares in Q4 2023, an estimated $868K.
  • B. Metzler seel. Sohn & Co first reported a position in Health Catalyst in Q1 2022 and held it in 7 quarters.
  • B. Metzler seel. Sohn & Co's Health Catalyst position peaked at $2.02M in Q2 2023.
  • 167 funds tracked by Wall St. Rank held Health Catalyst as of Q4 2023.

Based on B. Metzler seel. Sohn & Co's 13F filing for Q4 2023, filed 13 Feb 2024.